NCT03124004|Unknown
Evaluation of the Intra- and Post- Operative Bleeding After Periodontal Debridement in Direct Anticoagulant Patients
NOADB_db
Loading search results
NOADB_db
Sponsor study identifier
observational
128
1 country
1
Study Start
August 15, 2016
Actual (reported)Primary Completion
November 15, 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
November 15, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Direct Oral Anticoagulants were recently approved for medical treatment of several condition such as, non valvular atrial fibrillation, deep venous thrombosis, and others, substituting sometimes the conventional oral anticoagulants. The aim of the present study is to observe the possible difference in intra-operative and post-operative bleeding events for periodontal debridement.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 15, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
August 15, 2016
Actual (reported)March 30, 2017
Actual (reported)April 21, 2017
Actual (reported)November 15, 2017
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
November 15, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
intra-operative bleeding
intra-operative bleeding is registered as follows: mild if stopped in 20 seconds; medium: if stopped after not more than one minute; severe: if not stopped.
30 minutes
post-operative bleeding events
1 week
oral health status
1 week before
assuming Pradaxa or Eliquis or Apixaban or Xarelto; undergoing periodontal debridement
assuming Coumadin or Sintrom; undergoing periodontal debridement
with ultrasonic device supragingival and subgingival full-mouth debridement is provided
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Cardiovascular patient assuming oral anticoagulant therapy (conventional or direct)
Clinica Odontoiatrica e Stomatologica
Trieste, 34100, Italy
Roberto Di Lenarda, Prof.
University of Trieste
Federico Berton, Dr.
University of Trieste
Fulvia Costantinides, Dr.
University of Trieste
Gaetano Castronovo, Dr.
University of Trieste
First Submitted
March 30, 2017
First Posted
April 21, 2017
Study Start
August 15, 2016
Actual (reported)Primary Completion
November 15, 2017
Estimated (date passed)Serum A.Actinomycetemcomitans Antibodies and Periodontitis
cardiological assessment
1 week before
bleeding risk assessment
1 week before
Contact the study team to confirm eligibility.
This estimate has passed. The registry has not confirmed an actual date for this milestone.
Study Completion
November 15, 2018
Estimated (date passed)This estimate has passed. The registry has not confirmed an actual date for this milestone.
Last Updated
April 21, 2017
Record last verified: 2017-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: